Loading...
Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial
AIMS: To elucidate the effects of intensive LDL-C lowering treatment with a standard dose of statin and ezetimibe in patients with dyslipidaemia and high risk of coronary events, targeting LDL-C less than 70 mg/dL (1.8 mmol/L), compared with standard LDL-C lowering lipid monotherapy targeting less t...
Na minha lista:
| Udgivet i: | Eur Heart J |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5837267/ https://ncbi.nlm.nih.gov/pubmed/28430910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehx162 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|